Thrombosis Perspective

 
 
  • S2 Episode 6: Neoadjuvant Therapy and Renal Cell Carcinoma   Drs Sumanta Pal and Jose A. Karam discuss neoadjuvant therapy in renal cell carcinoma, including TKIs, IO, and the need for more studies to explore the role of neoadjuvant therapy in RCC.
  • Episode 10: Approach to Cardiotoxicity: Art That Needs More Science   Drs Michelle Kittleson and Bonnie Ky discuss the field of cardio-oncology and how cancer treatment-related cardiotoxicity can be prevented, detected, and treated to improve the quality of cancer survivorship.
  • Episode 5: Liver-Directed Therapy for Colorectal Cancer   How do you know if your patient will benefit from liver-directed therapy for colorectal cancer? Join experts Drs Benjamin Schlechter and Ammar Sarwar as they discuss.
  • Sep 01 2023 This Week in Cardiology   ESC Wrap-up 1: Obesity, heart failure with preserved EF and reduced EF, AF, frailty, evidence translation, and catheter ablation are the topics John Mandrola, MD, discusses in this week’s podcast.
  • ESC 2023 How Much AF Warrants Anticoagulation? Electrophysiologist John Mandrola reviews the NOAH-AFNET 6 trial presented at the European Society of Cardiology Congress 2023, which compared edoxaban vs placebo in patients with atrial high-rate episodes.
  • Aug 25 2023 This Week in Cardiology   GLP-1 agonists in HFpEF, DOACs for subclinical AF, renal denervation, and the matter of remaining in the profession are the topics John Mandrola, MD, discusses in this week’s podcast.
  • ESC 2023 Mandrola's 5 Things to Look for at ESC 2023 Electrophysiologist John Mandrola, MD, picks his top trials and themes from the upcoming European Society of Cardiology congress in Amsterdam.
  • Aug 18 2023 This Week in Cardiology   ICD generator change, less is more in VT management, co-morbidity in HF, and SGLT2i after AF ablation are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Statins vs Fibrates in Dyslipidemia Dr Vega discusses readers' responses to managing dyslipidemia in a woman with multiple risk factors for cardiovascular disease.
  • Healing Osteomyelitis After Intertrochanteric Femur Fracture A 62-year-old man's late postoperative infection after hip fracture surgery developed into osteomyelitis, but over a 2-year period he was able to achieve fracture union and decreased bacterial burden.
  • When Your Patient Has Had a Clot: Expert Advice   Provoked vs unprovoked, testing vs no testing, the patient taking a long airplane trip. An expert weighs in on these issues and more.
  • Aug 11 2023 This Week in Cardiology   Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Aug 04 2023 This Week in Cardiology   Listener feedback re observational studies, surgeons’ dissent from recent guidelines, aspirin for primary prevention, and fish oil are the topics discussed by John Mandrola.MD in this week's podcast.
  • Why Is Cuff Size So Important and Other Factors That Affect Accurate Blood Pressure Measurement Accurate measurement of blood pressure is essential for the diagnosis, treatment, and control of hypertension—the most common CVD risk factor—yet correct measurement technique is not regularly followed in clinical practice. This review highlights aspects of obtaining accurate results, particularly the importance of choosing the correct cuff size.
  • Neutral But Useful Studies From ESOC   Hans-Christoph Diener reviews some neutral studies presented at the 2023 European Stroke Organization Conference.
  • Episode 8: An Espresso-Shot on Hypertrophic Cardiomyopathy   Drs Michelle Kittleson and Carolyn Ho have a delightful discussion about effective diagnosis and management for individuals with hypertrophic cardiomyopathy.
  • Highlights on Thrombosis and Hemostasis From EHA 2023   Thrombosis and hemostasis highlights from EHA 2023 identify VTE as a major complication in acute promyelocytic leukemia, biomarkers for VTE in lung cancer, and an investigational thrombosis inhibitor.
  • The Most Important Question in Medicine   Ask it often enough and it will eventually save someone's life.
  • Jun 23 2023 This Week in Cardiology   Starting HF meds during hospitalization for HF, Impella, testosterone, and colchicine are the topics John Mandrola, MD, discusses in this week's podcast.
  • Is Long COVID Really 'Long Everything'?   Long COVID is real, but whether this syndrome is a unique sequela of SARS-CoV-2 infection is another question.